Brain Tumors
An ongoing clinical study is currently taking place Canada and Switzerland.
The purpose of this study is to evaluate the Safety and Feasibility of Transcranial MRI-Guided Focused Ultrasound Surgery in the Treatment of Brain Tumors.
Contact information:
Sunnybrook Health Science Centre, Toronto, Canada.
(Please refer to this study by its ClinicalTrials.gov identifier: NCT01473485 )
Sunnybrook Health Science Centre, Toronto, Canada
Julie Gundry 416-480-6100, ext 7362
julie.gundry@sunnybrook.ca
Principal Investigator: Todd Mainprize, MD
For more information on this study please visit clinical trials.gov.
Zurich University Children's Hospital, Zurich, Switzerland
Treating physicians: Javier fandino and Ernst martin
Contact email: ernst.martin@kispi.uzh.ch
Functional Neurosurgery
Neuropathic Pain
An ongoing clinical study is currently taking place at two sites:
- The Center of Ultrasound Functional Neurosurgery, Solothurn, Switzerland
- Zurich University, Zurich, Switzerland.
Who can participate in the Neuropathic Pain study?
Patients who are suffering from chronic, therapy resistant pain, and are willing to participate in a clinical trial and attend all study visits.
This study is currently recruiting participants.
Contact information:
The Center of Ultrasound Functional Neurosurgery, Solothurn, Switzerland
Prof. Dr. med. Daniel Jeanmonod +41 32 621 79 32
daniel.jeanmonod@sonimodul.ch
Principal Investigator: Prof. Dr. med. Daniel Jeanmonod M.D
Website
Essential Tremor (ET)
An ongoing clinical study is currently taking place at the University of Virginia, Charlottesville, Virginia, United States.
The purpose of this study is to evaluate the safety and initial effectiveness of MRgFUS thermal ablation of a designated area in the brain of patients suffering from medication-refractory Essential Tremor.
This study is currently not recruiting participants.
If you have questions about the study please contact:
University of Virginia
Tel: 434-243-1435
Email: fusbrain@virginia.edu
Principal Investigator: William Jeff Elias, MD
or visit www.clinicaltrials.gov.
To view preliminary results about the essential tremor study taking place at the University of Virginia click here.
Early results of essential tremor study promising (Richmond Times-Dispatch, June 13, 2011).
Richmond Times-Dispatch staff writer Karin Kapsidelis wrote in March about Billy R. Williams, who in February was treated at the University of Virginia for essential tremor.
Click here to read the full report.
Movement Disorders
An ongoing clinical study is currently taking place at the Center of Ultrasound Functional Neurosurgery, Solothurn, Switzerland.
The purpose of this study is to further investigate the precision and safety of MRgFUS for tissue ablation in the thalamus, subthalamus and pallidum, as well as collect initial clinical efficiency data for long-term chronic, therapy-resistant movement disorders patients (Parkinson's disease or tremor).
Who can participate in the Movement Disorders study?
Patients who are suffering from long-term chronic, therapy-resistant movement disorders (Parkinson's disease or tremor), and are willing to participate in a clinical trial and attend all study visits.
This study is currently recruiting participants.
How can you find out more?
If you have questions or are interested in participating, please contact:
Prof. Dr. med. Daniel Jeanmonod +41 32 621 79 32
daniel.jeanmonod@sonimodul.ch
Principal Investigator: Prof. Dr. med. Daniel Jeanmonod M.D
Website
For more information please contact us.
